Tag: Tuberculosis
12.6 Million in U.S. Could Benefit From Tx to Prevent Active TB
Revised NHANES-based estimate for prevalence of latent TB infection excludes those who report prior tx
Tuberculosis Rates for U.S. Children Are Low and Declining
Disparities persist by race, ethnicity, geography; incidence higher for those living in U.S.-affiliated islands
Recs Updated for TB Screening, Treatment in Health Care Workers
Guidelines include preplacement TB risk assessment, postexposure symptom evaluation and testing
CDC: TB Incidence Declined Slightly in United States in 2017
Number of cases, disease incidence decreased globally, but more progress needed to meet targets
One-Month Regimen Noninferior for Preventing HIV-Related TB
One-month rifapentine, isoniazid noninferior to nine months of isoniazid alone
Short Regimen Noninferior for Rifampin-Resistant Tuberculosis
Short regimen of nine to 11 months noninferior to 20-month regimen following WHO guidelines
Stratifying by Severity May Allow Shorter TB Tx Regimens
Those with minimal disease may be cured with a four-month versus six-month treatment regimen
Relapse-Free Cure From MDR-TB Higher Than Anticipated
Per simplified outcome definition, frequency similar in low-, intermediate-, high-incidence countries
MICs of Isoniazid, Rifampin May Predict Tuberculosis Relapse
Higher MIC in pretreatment M. tuberculosis isolates linked to relapse risk
Rifampin Effective for Latent Tuberculosis in Children
Rifampin has advantage of being a shorter, single-drug regimen that is palatable for children
